It is not recommended to use Semaglutide or Tirzepatide if you are taking blood thinning medications
Gliptins as a group constitute a widely accepted therapy for the management of T2DM, usually as a second-line medication
Latorre A, Couleaud P, Aires A, Cortajarena AL, Somoza A
Injectable Dosage (Subcutaneous or Intramuscular) Typical Range: 250500 mcg per day Administration: Inject subcutaneously near the injury site or systemically (abdomen) for full-body support Split doses (e.g., 250 mcg morning, 250 mcg evening) are common for sustained healing response Often used for 24 weeks , then cycled off or tapered depending on recovery progress BPC-157 promotes tendon outgrowth, cellular survival, and healing when administered directly into or near damaged soft tissues (Gwyer et al., Frontiers in Pharmacology)
Diabetes Care, 43(Suppl 1), S66S76
At SeeBeyond Medicine, we are committed to providing the best possible care and helping our patients achieve their health goals.